Oncopharmpod
Enfortumab-vedotin (& Asciminib)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:16:27
- More information
Informações:
Synopsis
Closing out the year discussing FDA's approval of enfortumab-vedotin for urothelial cancer and a new, but pharmacologically unique, TKI with activity in CML (12:45). Happy New Year!
